News | March 24, 2015

Agency reports 8,739 MQSA-certified facilities as of March 1

March 24, 2015 — The U.S. Food and Drug Administration (FDA) released an updated Mammography Quality Standards Act and Program (MQSA) Scorecard, which offers answers to the most commonly requested national statistics regarding the MQSA program. These statistics are updated on the first of each month.

 

Certified facilities, as of October 1, 2014

8,720

Certification statistics, as of March 1, 2015

 

  

Total certified facilities / Total accredited units

8,739 / 14,017

 

Certified facilities with FFDM2 units / Accredited FFDM units

8,325 / 13,493

FY 2015 inspection statistics, as of March 1, 2015

 

 

Facilities inspected

3,042

 

Total units at inspected facilities

4,820

 

Percent of inspections where the highest noncompliance was a:

 

 

  

Level 1 violation

0.6%

 

 

Level 2 violation

9.9%

 

 

Level 3 violation

2.6%

 

Percent of inspections with no violation

86.9%

Total annual mammography procedures reported, as of March 1, 20151

38,726,290

 

1 This number is an aggregate of the total number of procedures performed annually as reported by facilities to their accreditation bodies. Facilities are asked to disclose this information at their initial accreditation, and then at the time of their re-accreditation, which takes place once every three years. FDA began collecting these data in 1998. The aggregate does not reflect the current number of procedures performed at these facilities, but only the numbers reported by them during the three-year period prior to the current date. We have aggregated only the numbers reported by certified, non-Veterans Administration facilities.
2 FFDM - Full Field Digital Mammography unit.

For more information: www.fda.gov


Related Content

News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now